Research compound profile
NAD+
β-Nicotinamide adenine dinucleotide (oxidized) · redox cofactor — metabolic & signaling models in literature
NAD+ (oxidized nicotinamide adenine dinucleotide) is described in biochemistry texts and papers as a central electron carrier and enzyme cosubstrate—not as a peptide sequence. Catalog materials may be supplied as a specific salt or hydrate; identity, purity, and intended grade are defined on your COA and product listing, not by this overview. NEXT lists materials for authorized research use only—not for human dietary supplements, IV wellness programs, clinical treatment, or compounding for patients.
Compound specifications
Mechanism — research framing
- Redox shuttling: The NAD+/NADH pool couples hundreds of dehydrogenase reactions; steady-state ratios are tissue- and compartment-specific in research readouts.
- Sirtuin / ADP-ribosylation enzymes: NAD+ is consumed as a substrate in biochemical studies of sirtuins, PARPs, and related pathways—interpretation is model-dependent.
- CD38 / NADases: Literature discusses extracellular and membrane-associated NAD+ cleavage affecting available pools in experimental systems.
- Salvage & biosynthesis: NAMPT-mediated salvage and de novo routes appear in reviews on how cells maintain dinucleotide levels under stress protocols.
Areas of research interest (literature)
- Cell culture supplementation with defined media matrices and concentration series.
- Enzyme kinetics and inhibitor screening on NAD+-dependent dehydrogenases.
- Mitochondrial respiration and bioenergetics assays as reported under instrument-specific protocols.
- Aging-biology and senescence models where NAD+ precursors or flux are experimental variables—human translation is not summarized here.
- Analytical identity (HPLC, MS) and stability under storage conditions relevant to your lab SOPs.
Peptide regulations & site policy
- RUO: Materials are sold for research use only. They are not drugs, supplements, or cosmetics for human or animal use unless your program holds all required authorizations.
- FDA / FTC: Investigational compounds are not FDA-approved for the uses discussed in lay media. This page is educational; it does not diagnose, treat, cure, or prevent any disease.
- No clinical instructions: NEXT does not provide dosing, reconstitution for injection in humans, cycle advice, or prescribing information.
- Jurisdiction: Import, possession, and use of research peptides are regulated differently by country and state. You are responsible for lawful conduct in your location.
- COA & chain of custody: Batch documentation is provided per catalog policy; storage, handling, and record-keeping are your laboratory’s responsibility.
- Wholesale / retail paths: Volume and institutional purchasing follow B2B membership rules after approval; retail checkout follows discount membership and storefront terms.